John Bakewell

John Bakewell joined the Neuronetics Board of Directors in May 2020. Mr. Bakewell has served in senior executive roles for nearly three decades, building and executing business strategies for growth companies across the medical device, specialty pharma, diagnostics and healthcare provider sectors, while also serving on public- and private-company boards.
Mr. Bakewell’s professional experience in the medical technology industry includes serving for nine years as Executive Vice President and Chief Financial Officer of Wright Medical Group, Inc., from its private equity-backed reorganization through the company’s initial public offering, multiple years of industry-leading growth and creation of its industry-leading lower extremities franchise; Vice President, Finance and Administration and CFO of Cyberonics Inc., during a crucial five year period as the company successfully developed, gained regulatory approval, launched and globally commercialized its breakthrough device-based therapy for epilepsy; Chief Financial Officer of Lantheus Holdings, Inc., a specialty pharmaceutical company providing radiopharmaceuticals and contrast agents for cardiovascular imaging; Executive Vice President and Chief Financial Officer of RegionalCare Hospital Partners, Inc., a private equity-sponsored hospital acquirer and operator; and Chief Financial Officer of Exact Sciences Corporation, a molecular diagnostics company commercializing a DNA screening test for the early detection of colon cancer. Altogether, Mr. Bakewell has served in executive capacities for 26 years with eight organizations (of which five were public companies), including experience beyond healthcare in the technology and industrial sectors. He began his career as a CPA with seven years, collectively, at KPMG and Ernst & Young serving growth-oriented businesses across multiple industries. Mr. Bakewell holds a Bachelor of Arts in Accounting from the University of Northern Iowa and is a certified public accountant (current status inactive).
Since 2017 Mr. Bakewell has served on the board of directors of Xtant Medical Holdings, Inc., a publicly-traded manufacturer and marketer of class-leading regenerative medicine products and medical devices, where he chairs the audit committee. He has previously served on several other public and private company boards, including Entellus Medical, Inc., then a NASDAQ-traded ENT-focused medical device company, serving as compensation committee chair and audit committee member until its acquisition; ev3, Inc., then a NASDAQ-traded, endovascular medical device company, serving as audit committee chair and nominating/corporate governance committee member until its acquisition; Corindus Vascular Robotics, Inc., then a NASDAQ-traded medical technology company and the global leader in robotic-assisted vascular interventions, serving as audit committee chair; and Keystone Dental, Inc., a private, dental implant medical device company, serving as audit committee chair until its merger.